These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8217066)

  • 1. Predicting therapeutic results with levoprotiline and maprotiline in major depression: the role of the outcome criteria.
    Filip V; Höschl C; Karen P; Seifertová D; Bornová L; Prasková H; Prasko J
    Br J Psychiatry Suppl; 1993 Sep; (21):35-8. PubMed ID: 8217066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of a clinical trial of levoprotiline].
    Höschl C; Filip V; Bornová L; David I; Karen P; Seifertová D
    Cesk Psychiatr; 1992 Jun; 88(2):97-105. PubMed ID: 1505054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamics of the effects of levoprotiline and maprotiline on EEG in patients with major depressive episodes (DSM-III-R)].
    David I; Filip V; Höschl C; Albrecht V; Palus M; Seifertová D; Prasková H
    Cesk Psychiatr; 1993 Jun; 89(3):123-9. PubMed ID: 8353827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives.
    Emrich HM; Berger M; Riemann D; von Zerssen D
    Pharmacopsychiatry; 1987 Mar; 20(2):60-3. PubMed ID: 3108909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of levoprotiline and amitriptyline in endogenous depressions.
    Faltus F; Molcan J; Svestka J; Náhunek K; Mrna B; Zapletálek M; Krekule P; Janecková E; Koníková M; Pazdírek S
    Act Nerv Super (Praha); 1989 Dec; 31(4):279-80. PubMed ID: 2638109
    [No Abstract]   [Full Text] [Related]  

  • 6. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recurrence of unipolar depression and efficacy of maprotiline].
    Rouillon F; Phillips R; Serrurier D; Ansart E; Gérard MJ
    Encephale; 1989; 15(6):527-34. PubMed ID: 2693074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaco-EEG profile of levoprotiline: second example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs.
    Herrmann WM; Schärer E; Wendt G; Delini-Stula A
    Pharmacopsychiatry; 1991 Nov; 24(6):206-13. PubMed ID: 1812497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter evaluation of maprotiline hydrochloride for treatment of depression.
    Clin Ther; 1984; 6(2):155-62. PubMed ID: 6367987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of tianeptine in treating major recurrent unipolar depression. Study versus placebo for 16 1/2 months of treatment].
    Daléry J; Dagens-Lafant V; De Bodinat C
    Encephale; 1997; 23(1):56-64. PubMed ID: 9172969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood concentrations of maprotiline in depressive patients].
    Rouillon F; Sioufi A; Serrurier D; Mizon JP; Plaquet R; Richard JB; Riche C; Bourin M; Kergueris MF; Besançon G
    Encephale; 1988; 14(4):299-305. PubMed ID: 3058453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Position of levoprotiline in the treatment of acute endogenous depression.
    Náhunek K; Svestka J; Cesková E; Rysánek R; Obrovská V; Misurec J; Wendt G
    Act Nerv Super (Praha); 1989 Dec; 31(4):280-1. PubMed ID: 2638110
    [No Abstract]   [Full Text] [Related]  

  • 15. Sustained efficacy of gepirone-IR in major depressive disorder: a double-blind placebo substitution trial.
    Amsterdam JD; Brunswick DJ; Gibertini M
    J Psychiatr Res; 2004; 38(3):259-65. PubMed ID: 15003431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Video rating analysis of effect of maprotiline in patients with dementia and depression.
    Fuchs A; Hehnke U; Erhart C; Schell C; Pramshohler B; Danninger B; Schautzer F
    Pharmacopsychiatry; 1993 Mar; 26(2):37-41. PubMed ID: 8378411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
    Amsterdam JD; Bodkin JA
    J Clin Psychopharmacol; 2006 Dec; 26(6):579-86. PubMed ID: 17110814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
    Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
    J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder.
    Feiger AD; Heiser JF; Shrivastava RK; Weiss KJ; Smith WT; Sitsen JM; Gibertini M
    J Clin Psychiatry; 2003 Mar; 64(3):243-9. PubMed ID: 12716264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.